Dalrymple-Alford JC - Search Results

1

Reproducibility and repeatability of magnetic resonance imaging in dementia.

Morgan CA, Roberts RP, Chaffey T, Tahara-Eckl L, van der Meer M, Günther M, Anderson TJ, Cutfield NJ, Dalrymple-Alford JC, Kirk IJ, Rose Addis D, Tippett LJ, Melzer TR. Morgan CA, et al. Among authors: dalrymple alford jc. Phys Med. 2022 Sep;101:8-17. doi: 10.1016/j.ejmp.2022.06.012. Epub 2022 Jul 16. Phys Med. 2022. PMID: 35849909

2

A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia.

McKinlay A, Grace RC, Dalrymple-Alford JC, Anderson T, Fink J, Roger D. McKinlay A, et al. Parkinsonism Relat Disord. 2008;14(1):37-42. doi: 10.1016/j.parkreldis.2007.05.009. Epub 2007 Jul 12. Parkinsonism Relat Disord. 2008. PMID: 17627863

3

Planning in Parkinson's disease: a matter of problem structure?

McKinlay A, Kaller CP, Grace RC, Dalrymple-Alford JC, Anderson TJ, Fink J, Roger D. McKinlay A, et al. Neuropsychologia. 2008 Jan 15;46(1):384-9. doi: 10.1016/j.neuropsychologia.2007.08.018. Epub 2007 Aug 31. Neuropsychologia. 2008. PMID: 17928014

4

Neuropsychiatric problems in Parkinson's disease: comparisons between self and caregiver report.

McKinlay A, Grace RC, Dalrymple-Alford JC, Anderson TJ, Fink J, Roger D. McKinlay A, et al. Aging Ment Health. 2008 Sep;12(5):647-53. doi: 10.1080/13607860802343225. Aging Ment Health. 2008. PMID: 18855181

5

Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson's disease.

Mace JL, Porter RJ, Dalrymple-Alford JC, Wesnes KA, Anderson TJ. Mace JL, et al. J Psychopharmacol. 2010 Oct;24(10):1465-72. doi: 10.1177/0269881109105721. Epub 2009 May 21. J Psychopharmacol. 2010. PMID: 19460872 Clinical Trial.

6

The effects of acute tryptophan depletion on mood in patients with Parkinson's disease and the healthy elderly.

Mace JL, Porter RJ, Dalrymple-Alford JC, Anderson TJ. Mace JL, et al. J Psychopharmacol. 2010 Apr;24(4):615-9. doi: 10.1177/0269881109105572. Epub 2009 Jul 22. J Psychopharmacol. 2010. PMID: 19625388 Clinical Trial.

7

Assessing cognitive impairment in Parkinson's disease: a comparison of two tower tasks.

McKinlay A, Grace RC, Kaller CP, Dalrymple-Alford JC, Anderson TJ, Fink J, Roger D. McKinlay A, et al. Appl Neuropsychol. 2009 Jul;16(3):177-85. doi: 10.1080/09084280903098661. Appl Neuropsychol. 2009. PMID: 20183170

8

The MoCA: well-suited screen for cognitive impairment in Parkinson disease.

Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, Melzer TR, Kirwan J, Keenan R, Wells S, Porter RJ, Watts R, Anderson TJ. Dalrymple-Alford JC, et al. Neurology. 2010 Nov 9;75(19):1717-25. doi: 10.1212/WNL.0b013e3181fc29c9. Neurology. 2010. PMID: 21060094

9

Characterizing mild cognitive impairment in Parkinson's disease.

Dalrymple-Alford JC, Livingston L, MacAskill MR, Graham C, Melzer TR, Porter RJ, Watts R, Anderson TJ. Dalrymple-Alford JC, et al. Mov Disord. 2011 Mar;26(4):629-36. doi: 10.1002/mds.23592. Epub 2011 Feb 1. Mov Disord. 2011. PMID: 21287603

10

Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease.

Melzer TR, Watts R, MacAskill MR, Pearson JF, Rüeger S, Pitcher TL, Livingston L, Graham C, Keenan R, Shankaranarayanan A, Alsop DC, Dalrymple-Alford JC, Anderson TJ. Melzer TR, et al. Brain. 2011 Mar;134(Pt 3):845-55. doi: 10.1093/brain/awq377. Epub 2011 Feb 9. Brain. 2011. PMID: 21310726 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page